CA1303619C - Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same - Google Patents
Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the sameInfo
- Publication number
- CA1303619C CA1303619C CA000582165A CA582165A CA1303619C CA 1303619 C CA1303619 C CA 1303619C CA 000582165 A CA000582165 A CA 000582165A CA 582165 A CA582165 A CA 582165A CA 1303619 C CA1303619 C CA 1303619C
- Authority
- CA
- Canada
- Prior art keywords
- ginkgolides
- same
- alkoxy
- compositions containing
- therapeutic compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229930184727 ginkgolide Natural products 0.000 title claims abstract description 7
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 239000000203 mixture Substances 0.000 title claims abstract 5
- 230000001225 therapeutic effect Effects 0.000 title claims abstract 3
- 125000003545 alkoxy group Chemical group 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims abstract 2
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 claims description 2
- 108010003541 Platelet Activating Factor Proteins 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 206010006482 Bronchospasm Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 230000007885 bronchoconstriction Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000033399 Anaphylactic responses Diseases 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-M Arachidonate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC([O-])=O YZXBAPSDXZZRGB-DOFZRALJSA-M 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 101001003187 Hordeum vulgare Alpha-amylase/subtilisin inhibitor Proteins 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 229940114078 arachidonate Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8725871 | 1987-11-04 | ||
| GB878725871A GB8725871D0 (en) | 1987-11-04 | 1987-11-04 | Ginkgolide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1303619C true CA1303619C (en) | 1992-06-16 |
Family
ID=10626449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000582165A Expired - Lifetime CA1303619C (en) | 1987-11-04 | 1988-11-03 | Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPH0686455B2 (da) |
| KR (1) | KR970005536B1 (da) |
| AT (1) | AT397097B (da) |
| AU (1) | AU616367B2 (da) |
| BE (1) | BE1003455A3 (da) |
| CA (1) | CA1303619C (da) |
| CH (1) | CH675583A5 (da) |
| DE (1) | DE3837550A1 (da) |
| DK (1) | DK612788A (da) |
| ES (1) | ES2009364A6 (da) |
| FI (1) | FI90081C (da) |
| FR (2) | FR2622448B1 (da) |
| GB (2) | GB8725871D0 (da) |
| GR (1) | GR1000264B (da) |
| HK (1) | HK53992A (da) |
| IE (1) | IE61541B1 (da) |
| IN (1) | IN173404B (da) |
| IT (1) | IT1227456B (da) |
| MA (1) | MA21423A1 (da) |
| MY (1) | MY103446A (da) |
| NL (1) | NL8802635A (da) |
| NO (1) | NO167739C (da) |
| NZ (1) | NZ226738A (da) |
| PT (1) | PT88924B (da) |
| SE (1) | SE8803931L (da) |
| SG (1) | SG48292G (da) |
| TN (1) | TNSN88118A1 (da) |
| ZA (1) | ZA888184B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5895785A (en) * | 1987-10-20 | 1999-04-20 | Ruth Korth | Treatment and prevention of disorders mediated by LA-paf or endothelial cells |
| DE69132379T2 (de) * | 1990-06-06 | 2001-03-01 | Ruth-Maria Korth | Behandlung von Erkrankungen mit Paf-Antagonisten und Verfahren zur Bestimmung deren Wirksamkeit |
| ES2181665T3 (es) * | 1991-11-04 | 2003-03-01 | Ruth-Maria Korth | Tratamiento y prevencion de enfermedades mentales, acompañadas por unos elevados niveles de liso paf, con los antagonistas de paf. |
| FR2763592B1 (fr) * | 1997-05-20 | 1999-07-16 | Sod Conseils Rech Applic | Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant |
| FR2777280B1 (fr) * | 1998-04-10 | 2001-04-20 | Centre Nat Rech Scient | Derives de ginkgolides, leur procede de preparation et compositions pharmaceutiques les contenant |
| KR102105451B1 (ko) | 2015-12-18 | 2020-04-28 | 청두 바이위 징코라이드 파마슈티컬즈 컴퍼니 리미티드 | 징코라이드b 유도체, 그 제조 방법 및 응용 |
| CN108383852B (zh) * | 2017-12-25 | 2019-11-22 | 上海信谊百路达药业有限公司 | 一种从银杏叶中提取的银杏内酯化合物及其制备 |
| CN108373474B (zh) * | 2017-12-25 | 2020-06-09 | 上海信谊百路达药业有限公司 | 一种从银杏叶中提取的银杏内酯化合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8418424D0 (en) * | 1984-07-19 | 1984-08-22 | Scras | Inhibition of platelets aggregation |
| DE3710921C2 (de) * | 1986-10-21 | 1996-09-26 | Korth Ruth | Verwendung der Gingkolide BN 52020, BN 52021 und BN 52063 zur Behandlung von Arteriosklerose |
| DE3735525C2 (de) * | 1987-10-20 | 1997-02-20 | Korth Ruth Maria | Verfahren zur Bestimmung der Wirksamkeit von paf-Acether-Rezeptor-Antagonisten |
-
1987
- 1987-11-04 GB GB878725871A patent/GB8725871D0/en active Pending
-
1988
- 1988-10-24 GB GB8824859A patent/GB2211841B/en not_active Expired - Lifetime
- 1988-10-26 NL NL8802635A patent/NL8802635A/nl not_active Application Discontinuation
- 1988-10-26 IN IN928DE1988 patent/IN173404B/en unknown
- 1988-10-26 GR GR880100726A patent/GR1000264B/el unknown
- 1988-10-27 NZ NZ226738A patent/NZ226738A/xx unknown
- 1988-10-28 MY MYPI88001236A patent/MY103446A/en unknown
- 1988-10-28 BE BE8801244A patent/BE1003455A3/fr not_active IP Right Cessation
- 1988-10-31 SE SE8803931A patent/SE8803931L/xx not_active Application Discontinuation
- 1988-11-01 ZA ZA888184A patent/ZA888184B/xx unknown
- 1988-11-01 MA MA21665A patent/MA21423A1/fr unknown
- 1988-11-02 ES ES8803334A patent/ES2009364A6/es not_active Expired
- 1988-11-02 AT AT0269688A patent/AT397097B/de not_active IP Right Cessation
- 1988-11-02 FI FI885046A patent/FI90081C/fi not_active IP Right Cessation
- 1988-11-03 IE IE331588A patent/IE61541B1/en not_active IP Right Cessation
- 1988-11-03 TN TNTNSN88118A patent/TNSN88118A1/fr unknown
- 1988-11-03 PT PT88924A patent/PT88924B/pt not_active IP Right Cessation
- 1988-11-03 DK DK612788A patent/DK612788A/da not_active Application Discontinuation
- 1988-11-03 CA CA000582165A patent/CA1303619C/en not_active Expired - Lifetime
- 1988-11-03 NO NO884900A patent/NO167739C/no unknown
- 1988-11-03 CH CH4081/88A patent/CH675583A5/fr not_active IP Right Cessation
- 1988-11-03 AU AU24644/88A patent/AU616367B2/en not_active Ceased
- 1988-11-03 KR KR1019880014439A patent/KR970005536B1/ko active IP Right Grant
- 1988-11-04 FR FR888814393A patent/FR2622448B1/fr not_active Expired - Lifetime
- 1988-11-04 JP JP63277522A patent/JPH0686455B2/ja not_active Expired - Lifetime
- 1988-11-04 IT IT8822493A patent/IT1227456B/it active
- 1988-11-04 DE DE3837550A patent/DE3837550A1/de active Granted
- 1988-11-04 FR FR888814392A patent/FR2622584B1/fr not_active Expired - Lifetime
-
1992
- 1992-04-29 SG SG48292A patent/SG48292G/en unknown
- 1992-07-23 HK HK539/92A patent/HK53992A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100152206A1 (en) | Bicyclic Dihydropyrimidines and Uses Thereof | |
| Jenkins et al. | Synthesis and evaluation of. alpha.-[[(2-haloethyl) amino] methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of. alpha.-[(1-aziridinyl) methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins | |
| NO170487C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive vannloeselige camptothecin-analoger | |
| CA1303619C (en) | Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same | |
| RU2145849C1 (ru) | Применение аналогов ацилфульвена и фармацевтическая композиция на их основе | |
| US6376516B1 (en) | Noscapine and noscapine derivatives, useful as anticancer agents | |
| ES2257027T3 (es) | Derivados de dibenzo(a,g) quinolizinio y sus sales. | |
| US6051565A (en) | Farnesyl-protein transferase inhibitors | |
| EP0383171A2 (en) | 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders | |
| US4604400A (en) | Treating arthritis with 3-(N,N-dimethyl carbamoyl)pyrazolo[1,5-a]pyridine | |
| Heymans et al. | Structure-activity relationship in PAF-acether. 2. RAC-1-O-octadecyl-2-O-acetyl-3-O-[. gamma.-(dimethylamino) propyl] glycerol | |
| SU865127A3 (ru) | Способ получени спирооксазолидиндионов | |
| JPH01117881A (ja) | 抗腫瘍性およびウイルス性アルカロイド | |
| RU2154066C2 (ru) | Бензотиопираноиндазолы, фармацевтическая композиция на их основе и способ лечения опухоли | |
| KR20030095197A (ko) | 패혈증의 치료 방법 | |
| JPS61280492A (ja) | 新規なベルバン誘導体類およびその製造方法 | |
| SU1001855A3 (ru) | Способ получени 2-замещенных-1н-фенантро[9,10- @ ]имидазолов или их солей | |
| Aboul-Enein | Aminoglutethimide | |
| IE42766L (en) | Pharmaceutical preparations | |
| GB2202532A (en) | 4-benzylthiophene(or furan)-2-sulfonamides as antiglaucoma agents | |
| JPS6322069A (ja) | 複素多環式芳香族化合物 | |
| Rice | CYTOTOXIC LACTONES FROM SELECTED PLANTS AND ADENINE DERIVATIVES (ELEPHANTOPUS NUDATUS, RADERMACHIA SINICA) | |
| AU763093B2 (en) | Cytotoxic alkaloid derivatives including asmarine A and B isolated from a sponge | |
| US6048867A (en) | Biologically active rupununines | |
| AU2003204339B2 (en) | Cytotoxic Alkaloid Derivatives Including Asmarine A and B Isolated from a Sponge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |